Your browser doesn't support javascript.
loading
Refractory eosinophilic fasciitis successfully treated with infliximab: A case report.
Smigielska, Paulina; Czarny, Justyna; Kowalski, Jacek; Wilkowska, Aleksandra; Nowicki, Roman J.
Afiliación
  • Smigielska P; Department of Dermatology, Venereology and Allergology, Medical University of Gdansk, Gdansk, Poland.
  • Czarny J; Department of Dermatology, Venereology and Allergology, Medical University of Gdansk, Gdansk, Poland.
  • Kowalski J; Department of Pathomorphology, Medical University of Gdansk, Gdansk, Poland.
  • Wilkowska A; Department of Dermatology, Venereology and Allergology, Medical University of Gdansk, Gdansk, Poland.
  • Nowicki RJ; Department of Dermatology, Venereology and Allergology, Medical University of Gdansk, Gdansk, Poland.
J Scleroderma Relat Disord ; 6(2): 211-213, 2021 Jun.
Article en En | MEDLINE | ID: mdl-35386741
ABSTRACT
Eosinophilic fasciitis is a rare connective tissue disease of unknown etiology. Therapeutic options include high-dose corticosteroids and other immunosuppressive drugs. We present a typical eosinophilic fasciitis case, which did not respond to first-line treatment, but improved remarkably after infliximab administration. This report demonstrates that in case of initial treatment failure, infliximab might be a relatively safe and effective way of eosinophilic fasciitis management.
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: J Scleroderma Relat Disord Año: 2021 Tipo del documento: Article País de afiliación: Polonia

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: J Scleroderma Relat Disord Año: 2021 Tipo del documento: Article País de afiliación: Polonia